Intercept cuts 25% of workforce after NASH rejection from FDA esagonowsky Tue, 09/01/2020 – 15:14

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman esagonowsky Tue, 09/01/2020 – 11:30

HHS bids out massive $250M ad campaign to put hopeful spin on coronavirus pandemic: report bbulik Tue, 09/01/2020 […]

AstraZeneca shells out up to $60M to reserve more coronavirus shot capacity with Oxford Biomedica kblankenship Tue, 09/01/2020 […]

Scientists have taken a significant step forward in the search to find effective new drug candidates for the […]

Mitochondria are the power plants of our cells and play an important role in providing energy for normal […]

Florida State University researchers have developed a new material that could be used to make flexible X-ray detectors […]

Sanofi and Regeneron do not anticipate carrying out further research on Kevzara in COVID-19

Rybelsus is the world’s first and only oral GLP-1 receptor agonist

Clinical development of AZD1222 is progressing globally with late-stage clinical trials ongoing in the UK, Brazil and South […]